Literature DB >> 12941901

Human immunodeficiency virus type 1 protease regulation of tat activity is essential for efficient reverse transcription and replication.

Ann Apolloni1, C William Hooker, Johnson Mak, David Harrich.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Tat protein enhances reverse transcription, but it is not known whether Tat acts directly on the reverse transcription complex or through indirect mechanisms. Since processing of Tat by HIV protease (PR) might mask its presence and, at least in part, explain this lack of data, we asked whether Tat can be cleaved by PR. We used a rabbit reticulocyte lysate (RRL) system to make Tat and PR. HIV-1 PR is expressed as a Gag-Pol fusion protein, and a PR-inactivated Gag-Pol is also expressed as a control. We showed that Tat is specifically cleaved in the presence of PR, producing a protein of approximately 5 kDa. This result suggested that the cleavage site was located in or near the Tat basic domain (amino acids 49 to 57), which we have previously shown to be important in reverse transcription. We created a panel of alanine-scanning mutations from amino acids 45 to 54 in Tat and evaluated functional parameters, including transactivation, reverse transcription, and cleavage by HIV-1 PR. We showed that amino acids 49 to 52 (RKKR) are absolutely required for Tat function in reverse transcription, that mutation of this domain blocks cleavage by HIV-1 PR, and that other pairwise mutations in this region modulate reverse transcription and proteolysis in strikingly similar degrees. Mutation of Tat Y47G48 to AA also down-regulated Tat-stimulated reverse transcription but had little effect on transactivation or proteolysis by HIV PR, suggesting that Y47 is critical for reverse transcription. We altered the tat gene of the laboratory strain NL4-3 to Y47D and Y47N so that overlapping reading frames were not affected and showed that Y47D greatly diminished virus replication and conveyed a reverse transcription defect. We hypothesize that a novel, cleaved form of Tat is present in the virion and that it requires Y47 for its role in support of efficient reverse transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941901      PMCID: PMC224567          DOI: 10.1128/jvi.77.18.9912-9921.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity.

Authors:  M Ott; M Schnölzer; J Garnica; W Fischle; S Emiliani; H R Rackwitz; E Verdin
Journal:  Curr Biol       Date:  1999 Dec 16-30       Impact factor: 10.834

2.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.

Authors:  J M Péloponèse; C Grégoire; S Opi; D Esquieu; J Sturgis; E Lebrun; E Meurs; Y Collette; D Olive; A M Aubertin; M Witvrow; C Pannecouque; E De Clercq; C Bailly; J Lebreton; E P Loret
Journal:  C R Acad Sci III       Date:  2000-10

4.  Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.

Authors:  M K Hill; C W Hooker; D Harrich; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription.

Authors:  C W Hooker; W B Lott; D Harrich
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription.

Authors:  K A Mowen; J Tang; W Zhu; B T Schurter; K Shuai; H R Herschman; M David
Journal:  Cell       Date:  2001-03-09       Impact factor: 41.582

7.  Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat.

Authors:  K Verhoef; G Marzio; W Hillen; H Bujard; B Berkhout
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication.

Authors:  Vanessa Brès; Rosemary Kiernan; Stéphane Emiliani; Monsef Benkirane
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

Review 9.  HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction.

Authors:  M Götte; X Li; M A Wainberg
Journal:  Arch Biochem Biophys       Date:  1999-05-15       Impact factor: 4.013

10.  The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat.

Authors:  E Col; C Caron; D Seigneurin-Berny; J Gracia; A Favier; S Khochbin
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

View more
  15 in total

1.  In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.

Authors:  Stephen E Braun; Ran Taube; Quan Zhu; Fay Eng Wong; Akikazu Murakami; Erick Kamau; Markryan Dwyer; Gang Qiu; Janet Daigle; Angela Carville; R Paul Johnson; Wayne A Marasco
Journal:  Hum Gene Ther       Date:  2012-09       Impact factor: 5.695

2.  Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.

Authors:  Atze T Das; Bep Klaver; Alex Harwig; Monique Vink; Marcel Ooms; Mireille Centlivre; Ben Berkhout
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.

Authors:  Min-Hsuan Lin; Ann Apolloni; Vincent Cutillas; Haran Sivakumaran; Sally Martin; Dongsheng Li; Ting Wei; Rui Wang; Hongping Jin; Kirsten Spann; David Harrich
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

4.  Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.

Authors:  Jennifer L Welch; Hussein Kaddour; Patrick M Schlievert; Jack T Stapleton; Chioma M Okeoma
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 5.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

6.  HIV-1 Tat C-terminus is cleaved by calpain 1: implication for Tat-mediated neurotoxicity.

Authors:  Giovanni Passiatore; Slava Rom; Davide Eletto; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2008-10-31

7.  The RNA annealing mechanism of the HIV-1 Tat peptide: conversion of the RNA into an annealing-competent conformation.

Authors:  Martina Doetsch; Boris Fürtig; Thomas Gstrein; Sabine Stampfl; Renée Schroeder
Journal:  Nucleic Acids Res       Date:  2011-02-04       Impact factor: 16.971

8.  Dynamic interactions of the HIV-1 Tat with nucleic acids are critical for Tat activity in reverse transcription.

Authors:  Christian Boudier; Nicolas Humbert; Françoise Chaminade; Yingying Chen; Hugues de Rocquigny; Julien Godet; Olivier Mauffret; Philippe Fossé; Yves Mély
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

9.  Potent inhibition of HIV-1 replication by a Tat mutant.

Authors:  Luke W Meredith; Haran Sivakumaran; Lee Major; Andreas Suhrbier; David Harrich
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

10.  HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Dominique Coulaud; Laurence Hameau; Sophie Lafosse; Josette Jeusset; Isabelle Borde; Michèle Reboud-Ravaux; Tobias Restle; Robert J Gorelick; Eric Le Cam
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.